HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

De-Quan Li Selected Research

De-Quan Li Research Topics

Disease

31Dry Eye Syndromes (Dry Eye Syndrome)
02/2024 - 01/2002
15Inflammation (Inflammations)
11/2020 - 10/2003
5Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
11/2020 - 06/2010
4Burns
03/2017 - 07/2015
3Wounds and Injuries (Trauma)
07/2017 - 01/2015
2Infections
01/2015 - 11/2010
2Keratoconjunctivitis Sicca
02/2010 - 10/2003
1Corneal Injuries
02/2024
1Breast Neoplasms (Breast Cancer)
01/2020
1Cysts
01/2018
1Conjunctival Diseases
11/2015
1Blepharitis
10/2015
1Corneal Perforation
07/2015
1Dacryocystitis (Dacryoadenitis)
11/2012
1Rhinitis
12/2011
1Atopic Dermatitis (Atopic Eczema)
12/2011
1Conjunctivitis
12/2011
1Asthma (Bronchial Asthma)
12/2011
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2010
1Sjogren's Syndrome (Sjogren Syndrome)
02/2010
1Keratoconjunctivitis
02/2010
1Corneal Diseases (Corneal Disease)
02/2010
1Metaplasia
06/2007
1Dehydration (Water Stress)
04/2006
1Limbal Stem Cell Deficiency
04/2005

Drug/Important Bio-Agent (IBA)

14CytokinesIBA
10/2022 - 12/2004
10Matrix Metalloproteinases (MMPs)IBA
11/2016 - 12/2004
6Proteins (Proteins, Gene)FDA Link
01/2015 - 02/2003
5InterferonsIBA
11/2015 - 06/2007
4AlkaliesIBA
03/2017 - 07/2015
4Messenger RNA (mRNA)IBA
11/2016 - 02/2003
4Mitogen-Activated Protein KinasesIBA
09/2006 - 12/2004
3Doxycycline (Periostat)FDA LinkGeneric
01/2016 - 07/2006
3Interferon-gamma (Interferon, gamma)IBA
01/2014 - 06/2007
2InterleukinsIBA
10/2022 - 09/2011
2Interleukin-17 (Interleukin 17)IBA
01/2019 - 06/2010
2InflammasomesIBA
06/2017 - 03/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2016 - 01/2016
2Interleukin-6 (Interleukin 6)IBA
11/2016 - 06/2010
2Peptide Hydrolases (Proteases)FDA Link
01/2016 - 07/2015
2Azithromycin (Zithromax)FDA LinkGeneric
10/2015 - 11/2010
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2015 - 12/2011
2MucinsIBA
03/2014 - 06/2011
2Thymic Stromal LymphopoietinIBA
12/2011 - 06/2010
2Cholinergic Agents (Cholinergics)IBA
06/2007 - 01/2005
2MethylprednisoloneFDA LinkGeneric
09/2006 - 07/2006
2Phosphotransferases (Kinase)IBA
09/2006 - 12/2004
1ectoineIBA
02/2024
1Therapeutic UsesIBA
02/2024
1cathepsin SIBA
01/2022
1Sirolimus (Rapamycin)FDA Link
11/2020
1Interleukin-9 (Interleukin 9)IBA
11/2020
1Sodium ChlorideFDA LinkGeneric
01/2020
1TrehaloseIBA
01/2020
1LuciferasesIBA
01/2020
1Interleukin-27 (Interleukin 27)IBA
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1Caspase 8 (Caspase-8)IBA
06/2017
1Mitochondrial DNA (mtDNA)IBA
06/2017
1Butyrates (Butyrate)IBA
03/2017
1pterostilbeneIBA
01/2016
1Coloring Agents (Dyes)IBA
11/2015
1Fluorescein (Funduscein)FDA LinkGeneric
11/2015
1Carnitine (L-Carnitine)FDA LinkGeneric
08/2015
1peptidoglycan recognition proteinIBA
01/2015
1IntegrinsIBA
01/2015
1C-Type Lectins (C-Type Lectin)IBA
01/2015
1PeriostinIBA
01/2015
1dectin 1IBA
01/2015
1FlagellinIBA
03/2014
14-O-carboxymethylascochlorinIBA
03/2014
1OX40 LigandIBA
12/2011
1AllergensIBA
12/2011
1Interleukin-33IBA
09/2011
1LigandsIBA
09/2011
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
12/2010
1Nerve Growth Factors (Neurotrophins)IBA
12/2010
1Anti-Bacterial Agents (Antibiotics)IBA
11/2010
1Transforming Growth Factor beta (TGF-beta)IBA
09/2010
1Transforming Growth Factor beta2IBA
06/2010
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
06/2010
1Interleukin-22 (IL-22)IBA
06/2010
1Interleukin-23 (Interleukin 23)IBA
06/2010
1Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2010
1Interleukin-2 Receptor alpha SubunitIBA
02/2010
1Interleukin-2 (IL2)IBA
02/2010
1NexusIBA
09/2008
1SolutionsIBA
09/2006
1SaltsIBA
09/2006
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2006
1Saline SolutionIBA
07/2006
1ChemokinesIBA
04/2006
1Protein Kinases (Protein Kinase)IBA
10/2005
1CollagenIBA
04/2005
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2005

Therapy/Procedure

2Transplantation
07/2017 - 04/2005
2Therapeutics
11/2016 - 07/2006
1Aftercare (After-Treatment)
01/2018
1Microspheres (Microsphere)
09/2010
1Topical Administration
01/2005